CMX001 is an oral nucleotide lipid-conjugate anticipated to start a Phase 3 study later this year.
http://www.sys-con.com/node/2543898
http://www.sys-con.com/node/2543898
Stem Cell Research News: News on Stem Cell Research continually updated from thousands of sources around from the B Media Network.
No comments:
Post a Comment